Published in Cardiovascular Business Week, May 16th, 2006
GAAP net sales for the period totaled $2.6 billion, up 8% versus the 2005 first quarter. Schering-Plough does not record sales of its cholesterol joint venture with Merck & Co., Inc., as this venture is accounted for under the equity method. Including an adjustment of an assumed 50% of global cholesterol joint venture net sales, Schering-Plough's adjusted...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.